FI870200A - 7-(azabicykloalkyl) -kinolonkarboksylsyra- och nafthyridonkarboksylsyraderivat. - Google Patents

7-(azabicykloalkyl) -kinolonkarboksylsyra- och nafthyridonkarboksylsyraderivat. Download PDF

Info

Publication number
FI870200A
FI870200A FI870200A FI870200A FI870200A FI 870200 A FI870200 A FI 870200A FI 870200 A FI870200 A FI 870200A FI 870200 A FI870200 A FI 870200A FI 870200 A FI870200 A FI 870200A
Authority
FI
Finland
Prior art keywords
nafthyridon
carboxylsyra
quinolon
azabicycloalkyl
carboxyls
Prior art date
Application number
FI870200A
Other languages
English (en)
Finnish (fi)
Other versions
FI870200A0 (fi
Inventor
Uwe Petersen
Klaus Grohe
Thomas Schenke
Hermann Hagemann
Hans-Joachim Zeiler
Karl Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI870200A0 publication Critical patent/FI870200A0/fi
Publication of FI870200A publication Critical patent/FI870200A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI870200A 1986-01-21 1987-01-19 7-(azabicykloalkyl) -kinolonkarboksylsyra- och nafthyridonkarboksylsyraderivat. FI870200A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863601567 DE3601567A1 (de) 1986-01-21 1986-01-21 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate

Publications (2)

Publication Number Publication Date
FI870200A0 FI870200A0 (fi) 1987-01-19
FI870200A true FI870200A (fi) 1987-07-22

Family

ID=6292237

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870200A FI870200A (fi) 1986-01-21 1987-01-19 7-(azabicykloalkyl) -kinolonkarboksylsyra- och nafthyridonkarboksylsyraderivat.

Country Status (16)

Country Link
EP (1) EP0230274A3 (xx)
JP (1) JPS62169789A (xx)
KR (1) KR870007176A (xx)
CN (1) CN87100354A (xx)
AU (1) AU6746387A (xx)
DD (1) DD265401A5 (xx)
DE (1) DE3601567A1 (xx)
DK (1) DK29287A (xx)
FI (1) FI870200A (xx)
HU (1) HUT45531A (xx)
IL (1) IL81291A0 (xx)
NO (1) NO870126L (xx)
PL (1) PL263735A1 (xx)
PT (1) PT84135A (xx)
SU (1) SU1538897A3 (xx)
ZA (1) ZA87380B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0251308B1 (de) * 1986-07-04 1990-11-22 Chemie Linz Gesellschaft m.b.H. 4-Chinolon-3-carbonsäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
ZA877471B (en) * 1986-10-08 1988-04-05 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acid antibacterial agents
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
US4923879A (en) * 1987-07-31 1990-05-08 Warner-Lambert Company 1,8-Naphthyridines and their use as antibacterial agents
US4968799A (en) * 1987-07-31 1990-11-06 Warner-Lambert Company Antibacterial agents
US4992546A (en) * 1987-07-31 1991-02-12 Warner-Lambert Company Process for preparing 6,8-diazabicyclo[3.2.2]nonane derivatives
JPH0228178A (ja) * 1988-04-23 1990-01-30 Toyama Chem Co Ltd 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法
KR910003630B1 (ko) * 1988-06-17 1991-06-07 한국과학기술원 벤조일 아세틱 에스테르 유도체 및 그 제조방법
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
WO1991004972A1 (en) * 1989-10-06 1991-04-18 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
US5385913A (en) * 1989-10-06 1995-01-31 Pfizer Inc. 1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
FR2656611B1 (fr) * 1990-01-04 1992-05-07 Hoechst France Nouvelles quinolones, leurs sels, utiles comme agents antimicrobiens, procede de preparation et leur application a titre de medicaments et compositions les renfermant.
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
US6184380B1 (en) 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3281423A (en) * 1964-02-03 1966-10-25 Merck & Co Inc 1, 3-ethanopiperazines and process
EP0090424B1 (en) * 1982-03-31 1986-05-28 Sterling Drug Inc. New quinolone compounds and preparation thereof
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
IL74244A (en) * 1984-02-17 1988-06-30 Warner Lambert Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
IN166416B (xx) * 1985-09-18 1990-05-05 Pfizer

Also Published As

Publication number Publication date
IL81291A0 (en) 1987-08-31
CN87100354A (zh) 1987-09-02
PL263735A1 (en) 1988-07-21
ZA87380B (en) 1987-09-30
FI870200A0 (fi) 1987-01-19
EP0230274A3 (de) 1988-03-09
EP0230274A2 (de) 1987-07-29
NO870126L (no) 1987-07-22
PT84135A (en) 1987-02-01
SU1538897A3 (ru) 1990-01-23
DK29287A (da) 1987-07-22
DE3601567A1 (de) 1987-07-23
JPS62169789A (ja) 1987-07-25
HUT45531A (en) 1988-07-28
DK29287D0 (da) 1987-01-20
DD265401A5 (de) 1989-03-01
NO870126D0 (no) 1987-01-13
KR870007176A (ko) 1987-08-17
AU6746387A (en) 1987-07-23

Similar Documents

Publication Publication Date Title
MX8358A (es) Derivados de sacarosa.
NL300161I2 (nl) Carbostyrilderivaten.
DE3781845D1 (de) Benzimidazol-derivate.
FI874743A (fi) Tunnskiktsavdunstare foer fluider med hoeg viskositet.
NO872831D0 (no) Fremgangsmaate for fremstilling av nitrofuranderivater.
DE3777997D1 (de) Piperidinderivate.
FI870200A (fi) 7-(azabicykloalkyl) -kinolonkarboksylsyra- och nafthyridonkarboksylsyraderivat.
DE3768992D1 (de) Benzimidazol-derivate.
DE3761308D1 (de) 18-phenylestrane-derivate.
DE3769349D1 (de) Diphenyletherderivate.
NO885166D0 (no) Ergolinderivater.
DE3872153D1 (de) 25-hydroxy-vitamin-d3-derivate.
FI883963A0 (fi) Isoxazol- -karbolinderivat.
DE3786834D1 (de) 5-fluoro-uracil-derivate.
DE3778624D1 (de) Glucosylmoranoline-derivate.
DE3889644D1 (de) Pheophorbidderivate.
DE3780338D1 (de) Indenopyrimidin-derivate.
DE3781831D1 (de) Aralkylimidazolderivate.
DE3774759D1 (de) Alkenamid-derivate.
ATE79874T1 (de) Thiazinon-derivate.
DE3861208D1 (de) Hydroxyalkyl-triazolyl-derivate.
DE3785480D1 (de) Macrolid-derivate.
NO875230L (no) Imidazolderivater, samt fremgangsmaate for fremstilling derav.
DE3769757D1 (de) Hydrofluoren-derivate.
DE3866371D1 (de) Diphenylaethylen-derivate.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BAYER AKTIENGESELLSCHAFT